TLC-065

N/A

Report date: 2023/12/29 10:45:50
NME

Base Information

Drug NameTLC-065
Drug Alias NameTLC-065
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action2-amino-3-carboxymuconate-6-semialdehyde decarboxylase inhibitors
Targets2-amino-3-carboxymuconate-6-semialdehyde decarboxylase
Therapy Area/IndicationsNephrosisLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitobridge Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrsoBio Inc
Inactive CompaniesN/A
Active IndicationsNephrosisLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A